Manufacturing capacity doubled at its Glasgow site.

Evotec expanded its sterile pharmaceutical manufacturing facility in Glasgow, Scotland. The company has doubled its capacity for the aseptic GMP manufacture of pharmaceuticals to be used in clinical trials with the new facility being immediately operational.

Evotec’s formulations business is a provider of contract pharmaceutical development services for formulations of drugs intended for parenteral administration and the manufacture of formulated compounds for use in Phase I and Phase II trials.

Previous articleQuest to Use Bio-Rad Technology
Next articleOrganon and Dyax Ink Antibody Pact